New York, United States, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Chemiluminescence immunoassay (CLIA) is an immunological technique used for the detection and monitoring of chronic disorders. The diagnostic testing technique is carried out in a CLIA analyzer. These chemiluminescence immunoassays (CLIA) find extensive application in clinical diagnostics of various diseases, such as inherited genetic diseases, infectious diseases, and cardiovascular diseases, among others.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/chemiluminescence-immunoassay-market/request-sample
Chemiluminescence Immunoassay Market Drivers
The global market is driven by a number of factors, such as the growing product innovations and development of CLIA Systems by market players, integration of technological advancements to address growing diagnostic needs of chronic diseases, and rising demands for such diagnostic techniques to address the growing global diseased population. For instance, according to the American Diabetes Association, in 2018, around 34.2 million individuals in the U.S. were suffering from diabetes that constitutes 10.5% of the country’s population.
Furthermore, the pandemic caused by the novel coronavirus is also expected to upsurge the demand for novel chemiluminescence immunoassay solutions for diagnostics and testing purposes. The huge patient pool and the growing number of suspects being tested worldwide have created several opportunities within the market. For instance, according to the data reported to WHO, as of December 8, 2020, there have been 66.72 million confirmed cases of COVID-19, among which 1.53 million deaths have been reported.
Additionally, business decisions, strategic collaborations, agreements, mergers, and partnerships have positively influenced market growth. For instance, Abbott Laboratories signed and entered a contract worth USD 252.0 million with North West London Pathology (NWLP) to build up a supply chain of diagnostic equipment and consumables, including Abbott's Alinity ci-series diagnostics instruments within the two organizations.
Report Scope
| Report Metric | Details |
| Market Size | USD 12.73 Billion by 2030 |
| CAGR | 7.5% (2022-2030) |
| Historical Data | 2019-2020 |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, Regions |
| Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
| Key Companies Profiled/Vendors | DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Immunodiagnostic Systems, Siemens Healthineers, Beckman Coulter Inc., Hoffmann-La Roche, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Ortho Clinical Diagnostics |
| Key Market Opportunities | Product Developments and Technological Advancements |
| Key Market Drivers | Rising Demand for Chemiluminescence Immunoassay to Address the Surging Prevalence of Chronic Diseases |
Buy Now Full Report @ https://straitsresearch.com/buy-now/chemiluminescence-immunoassay-market
Regional Analysis
North America’s chemiluminescence immunoassay market is largely driven by the presence of developed healthcare infrastructure. Apart from this, the European regional market is anticipated to be the second-largest market on account of the growing prevalence of the disease, patient’s accessibility to advanced facilities, rising government initiatives to support research in chronic diseases diagnostics and treatment, and high healthcare expenditure. APAC’s Chemiluminescence Immunoassay Market to attain high growth rate during the forecast period.
Key Highlights
- The global chemiluminescence immunoassay market size was valued at USD 6.64 billion in 2021 and is projected to reach USD 12.73 billion by 2030 at a CAGR of 7.5% from 2022 to 2030.
- The infectious Disease Segment is expected to be the leading segment in Chemiluminescence Immunoassay Market during the forecast period.
- North America is expected to hold the highest market share in Chemiluminescence Immunoassay Market.
Key Players
- DiaSorin S.p.A.
- Abbott Laboratories
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Immunodiagnostic Systems
- Siemens Healthineers
- Beckman Coulter Inc.
- Hoffmann-La Roche
- Inova Diagnostics, Inc.
- Maccura Biotechnology Co., Ltd.
- Ortho Clinical Diagnostics
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/chemiluminescence-immunoassay-market/request-sample
Chemiluminescence Immunoassay Market: Segmentation
By Product
- Instruments
- Automated
- Semi-Automated
- Consumables
- Software and Services
By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
By End-User
- Hospitals and Clinics
- Medical and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Research Institutes
By Region
- Americas
- Europe
- Asia-Pacific
- The Middle East and Africa
Table of Content and Figure @ https://straitsresearch.com/report/chemiluminescence-immunoassay-market/toc
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview and Dynamics
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Chemiluminescence Immunoassay Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.6 Technological Landscape
3.7 Impact of COVID-19 on Chemiluminescence Immunoassay Market
4 Product Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Instruments
4.2.1 Market Size & Forecast (Value)
4.2.2 Automated
4.2.3 Semi-automated
4.3 Consumables
4.3.1 Market Size & Forecast (Value)
4.4 Software& Services
4.4.1 Market Size & Forecast (Value)
5 Application Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Oncology
5.2.1 Market Size & Forecast (Value)
5.3 Therapeutic Drug Monitoring
5.3.1 Market Size & Forecast (Value)
5.4 Cardiology
5.4.1 Market Size & Forecast (Value)
5.5 Endocrinology
5.5.1 Market Size & Forecast (Value)
5.6 Infectious Disease
5.6.1 Market Size & Forecast (Value)
5.7 Autoimmune Disease
5.7.1 Market Size & Forecast (Value)
5.8 Others
5.8.1 Market Size & Forecast (Value)
6 End-User Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 Hospitals & Clinics
6.2.1 Market Size & Forecast (Value)
6.3 Medical & Diagnostic Laboratories
6.3.1 Market Size & Forecast (Value)
6.4 Pharmaceutical & Biotechnology Companies
6.4.1 Market Size & Forecast (Value)
6.5 Research Institutes
6.5.1 Market Size & Forecast (Value)
6.6 Others
6.6.1 Market Size & Forecast (Value)
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 Americas
7.2.1 North America
7.2.1.1 The U.S.
7.2.1.1.1 By Product
7.2.1.1.2 By Application
7.2.1.1.3 By End-User
7.2.1.2 Canada
7.2.1.2.1 By Product
7.2.1.2.2 By Application
7.2.1.2.3 By End-User
7.2.2 South America
7.2.2.1 By Product
7.2.2.2 By Application
7.2.2.3 By End-User
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Western Europe
7.3.2.1 United Kingdom
7.3.2.1.1 By Product
7.3.2.1.2 By Application
7.3.2.1.3 By End-User
7.3.2.2 Germany
7.3.2.2.1 By Product
7.3.2.2.2 By Application
7.3.2.2.3 By End-User
7.3.2.3 France
7.3.2.3.1 By Product
7.3.2.3.2 By Application
7.3.2.3.3 By End-User
7.3.2.4 Spain
7.3.2.4.1 By Product
7.3.2.4.2 By Application
7.3.2.4.3 By End-User
7.3.2.5 Italy
7.3.2.5.1 By Product
7.3.2.5.2 By Application
7.3.2.5.3 By End-User
7.3.3 Eastern Europe
7.3.3.1 By Product
7.3.3.2 By Application
7.3.3.3 By End-User
7.3.4 The Rest of Europe
7.3.4.1 By Product
7.3.4.2 By Application
7.3.4.3 By End-User
7.4 Asia-Pacific
7.4.1 Market Size & Forecast (Value)
6.4.2 Japan
7.4.2.1 By Product
7.4.2.2 By Application
7.4.2.3 By End-User
7.4.3 China
7.4.3.1 By Product
7.4.3.2 By Application
7.4.3.3 By End-User
7.4.4 Australia
7.4.4.1 By Product
7.4.4.2 By Application
7.4.4.3 By End-User
7.4.5 India
7.4.5.1 By Product
7.4.5.2 By Application
7.4.5.3 By End-User
7.4.6 South Korea
7.4.6.1 By Product
7.4.6.2 By Application
7.4.6.3 By End-User
7.4.7 The Rest of Asia-Pacific
7.4.7.1 By Product
7.4.7.2 By Application
7.4.7.3 By End-User
7.5 The Middle East and Africa
7.5.1 The Middle East and Africa
7.5.1.1 By Product
7.5.1.2 By Application
7.5.1.3 By End-User
8 Company Profile
8.1 DiaSorin S.p.A.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 Immunodiagnostic Systems
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 Siemens Healthineers
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 Beckman Coulter Inc.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 F. Hoffmann-La Roche
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
8.8 Inova Diagnostics, Inc.
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Recent Developments
8.8.4 Product Portfolio
8.9 Maccura Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Recent Developments
8.9.4 Product Portfolio
8.10 Ortho Clinical Diagnostics
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Recent Developments
8.10.4 Product Portfolio
8.11 Others
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Recent Developments
8.11.4 Product Portfolio
12 Conclusion & Recommendations
13 Acronyms & Abbreviations
News Media
Increasing Prevalence of Chronic Disorders to Drive the Demand for Surgical Retractors Market
Have a Look at the Related Research Report
Wound Care Market: Information by Product (Advanced Wound Dressing, Surgical Wound Care), Application (Chronic Wounds and Acute Wounds), and Region — Forecast till 2030
Rehabilitation Equipment Market: Information by Product (Daily Living Aids, Exercise Equipment), Application (Physiotherapy, Occupational Therapy), End-User), and Region — Forecast till 2030
Health Insurance Market: Information by Distribution Channel (Direct Sales, Banks), Insurance Type (Diseases Insurance), Coverage (Point Of Services), and Region – Forecast till 2030
Canine Atopic Dermatitis Market: Information by Treatment Type (Glucocorticoids, Monoclonal Antibody), Route of Administration (Topical, Oral, Injectable), and Region — Forecast till 2030
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
